BARICORDI, Olavio
 Distribuzione geografica
Continente #
NA - Nord America 11.945
AS - Asia 6.818
EU - Europa 6.043
SA - Sud America 965
AF - Africa 149
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.941
Nazione #
US - Stati Uniti d'America 11.690
IT - Italia 2.764
SG - Singapore 2.394
CN - Cina 2.084
DE - Germania 823
BR - Brasile 763
UA - Ucraina 728
VN - Vietnam 691
HK - Hong Kong 503
TR - Turchia 381
GB - Regno Unito 367
FI - Finlandia 343
FR - Francia 235
RU - Federazione Russa 193
JP - Giappone 153
IN - India 148
SE - Svezia 134
CA - Canada 124
BD - Bangladesh 117
NL - Olanda 114
PL - Polonia 114
MX - Messico 87
AR - Argentina 62
ZA - Sudafrica 53
IQ - Iraq 51
ID - Indonesia 49
AT - Austria 42
EC - Ecuador 39
ES - Italia 32
CO - Colombia 30
TH - Thailandia 30
BE - Belgio 29
UZ - Uzbekistan 28
PK - Pakistan 27
MA - Marocco 26
VE - Venezuela 23
PH - Filippine 22
SA - Arabia Saudita 20
LT - Lituania 19
CH - Svizzera 18
CZ - Repubblica Ceca 16
MY - Malesia 16
CL - Cile 15
AE - Emirati Arabi Uniti 14
IR - Iran 14
EG - Egitto 13
IE - Irlanda 13
AU - Australia 12
CR - Costa Rica 11
KE - Kenya 11
PY - Paraguay 10
KZ - Kazakistan 9
PE - Perù 9
RO - Romania 9
TN - Tunisia 9
IL - Israele 8
MD - Moldavia 8
AZ - Azerbaigian 7
BO - Bolivia 7
ET - Etiopia 7
LB - Libano 7
OM - Oman 7
JM - Giamaica 6
JO - Giordania 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
BB - Barbados 5
DZ - Algeria 5
GR - Grecia 5
KR - Corea 5
NG - Nigeria 5
NO - Norvegia 5
PT - Portogallo 5
BG - Bulgaria 4
BY - Bielorussia 4
NI - Nicaragua 4
NP - Nepal 4
SN - Senegal 4
DK - Danimarca 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
AO - Angola 2
BH - Bahrain 2
BJ - Benin 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
PR - Porto Rico 2
QA - Qatar 2
SY - Repubblica araba siriana 2
Totale 25.919
Città #
Singapore 1.509
Ashburn 1.133
Woodbridge 1.029
Fairfield 917
San Jose 847
Chandler 732
Jacksonville 715
Houston 657
Beijing 572
Santa Clara 519
Hong Kong 495
Wilmington 377
Ann Arbor 375
Seattle 367
Hangzhou 326
Milan 293
Cambridge 292
New York 287
Ho Chi Minh City 247
Rome 233
Munich 214
Izmir 213
Los Angeles 191
Nanjing 189
Dallas 174
Tokyo 148
Princeton 146
Helsinki 138
Hanoi 137
Boardman 125
Lauterbourg 115
Warsaw 103
Addison 99
São Paulo 86
Shenyang 83
San Diego 79
Shanghai 71
The Dalles 71
Mexico City 69
Buffalo 66
Orem 64
Dearborn 62
Nanchang 62
Naples 57
Turku 57
Bologna 54
Ferrara 54
Hebei 52
Toronto 50
Turin 50
Hefei 45
Chennai 43
Changsha 42
Bremen 41
Tianjin 41
Falkenstein 40
Brooklyn 39
London 38
Montreal 37
Verona 37
Bari 36
Florence 35
Frankfurt am Main 35
Vienna 35
Denver 34
Jiaxing 34
Falls Church 33
Haiphong 32
Norwalk 30
San Mateo 30
Council Bluffs 29
Palermo 29
Chicago 28
Da Nang 28
Rio de Janeiro 28
Johannesburg 27
Kunming 27
Manchester 27
Bangkok 26
Mountain View 26
Stockholm 26
Tashkent 25
Brussels 24
Mumbai 24
Amsterdam 23
Baghdad 23
Moscow 23
Redwood City 23
Augusta 21
Atlanta 20
Brescia 19
Jinan 19
Philadelphia 19
Boston 18
Guangzhou 18
Zhengzhou 18
Modena 17
Brasília 16
Hải Dương 16
Padova 16
Totale 16.421
Nome #
Mutazione Q283P nel gene HFE in un eterozigote C282Y affetto da emocromatosi. 1.682
Associazione tra il polimorfismo c.1298A>C del gene MTHFR (Metilenetetraidrofolato Reduttasi) e l’artrite reumatoide 1.301
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 419
Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis 417
HLA-G molecules are constitutively expressed by synovial fibroblasts and up-modulated in osteoarthritis 320
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 295
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 254
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 250
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 248
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 244
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes 241
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 240
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 238
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 234
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 230
Emerging topics and new perspectives on HLA-G 223
Analisi del polimorfismo IVS2+4T>C del gene HFE in soggetti con sovraccarico di ferro. 216
The antibiotic polymyxin B modulates P2X7 receptor function 215
Purinoceptor function in the immune system 214
Reduced production of anti-inflammatory soluble HLA-G molecules in styrene exposed workers 214
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 213
Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease 212
A novel mutation of HFE explains the classical phenotype of hereditary hemochromatosis in a C282Y carrier 212
HLA-G expression is a fundamental prerequisite to pregnancy 210
Antigenes sHLA-G et polypose naso-sinusienne. 206
The antibiotic polymyxin B modulates P2X7 receptor function 204
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 200
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 199
Antigeni HLA e livelli sierici di HLA solubile nella malattia di Meniere 196
The c.1298A>C polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) gene is risk factor for Rheumatoid Arthritis 194
CYTOLYTIC P2X PURINOCEPTORS 194
Basal production of soluble HLA-G molecules by peripheral blood monocytes in patients with diisocyanate-induced asthma. 188
In vitro studies during long-term oral administration of specific transfer factor 187
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 183
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 182
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 182
Anti HLA class I monoclonal antibody effect on PKC kinetics in PHA activated human peripheral blood mononuclear and E+ cells 181
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 181
Human leukocyte antigen-A, -B, -C and -DR alleles and soluble human leukocyte antigen class I serum level in Meniere's disease. 179
Role of protein kinase C in the phosphatidylserine-induced inhibition of DNA synthesis in blood mononuclear cells 178
Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in Ulcerative Colitis and Crohn's disease: a non invasive diagnostic tools? 178
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 174
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II 174
The HLA-G genotype is associated with IL-10 levels in activated PBMCs 174
Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients. 173
Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip. 172
Utilizzo delle MSCs nel controllo del rigetto dei trapianti 172
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report 170
Allergic women have reduced sHLA-G plasma levels at delivery 169
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 169
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 169
Comment on "Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: Generation of IL-10 and induction of regulatory T cells" 168
HLA B51 antigen associated with neutrophil hyper-reactivity 168
P2 purinoceptors in the immune system 167
Farmacogenetica dei taxani nel trattamento del carcinoma mammario: possibile ruolo nell’identificazione del rischio di tossicità. 167
A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells 166
An anti-HLA class I monoclonal antibody alters the progression in the cell cycle of phytohemagglutinin-activated human T lymphocytes 165
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 165
MICA exon 5 microsatellite typing by DNA heteroduplex analysis: a new polymorphism in the transmembrane region 163
Increased production of soluble HLA-G molecules in stimulated peripheral blood mononuclear cells following extracorporeal photopheresis. Is it a mechanism involved in the therapeutic effect of the procedure? 162
Analisi dei genotipi ed aplotipi HFE nella popolazione Ferrarese 161
HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy 161
Production of sHLA-G molecules by “in vitro” matured cumulus-oocyte complex 160
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma. 160
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico e malattia. 158
Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression 158
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico, trattamenti e malattia. 158
Frequenze genotipiche ed aplotipiche HFE nella popolazione della Provincia di Ferrara 156
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 156
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 155
Transfer factor in chronic mucocutaneous candidiasis 155
New insights into HLA-G and inflammatory diseases 153
Association between MTHFR C.1298A > C polymorphism in the methylene-tetrahydrofolate (MTHFR) gene and increased risk for rheumatoid arthritis 153
Ruolo farmacogenetico del polimorfismo HLA-G 14bp nella risposta alla terapia con Methotrexate nell’artrite reumatoide. 153
Multipotent stromal cells skew monocytes towards an anti-inflammatory function: A role for HLA-G molecules 152
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 150
Associazione tra HLA-G e Lupus Eritematoso Sistemico. 150
The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients 149
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease? 147
Ruolo dell’HLA-G nel mantenimento del privilegio immune dell’occhio. 145
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma 144
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 144
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 143
Antibody-antigen interactions in dielectrophoresis buffers for cell manipulation on dielectrophoresis-based Lab-on-chip devices. 143
Programmable binding of single microspheres to single target tumor cells using a dielectrophoresis (DEP) based “lab-on-a-chip” array. 143
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 141
Il ruolo del polimorfismo HLA-G 14bp nell'invecchiamento. 139
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 139
Implication of immunosoppressive molecules during human oocyte maturation 136
A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential 136
Presenza di molecole solubili HLA-G nel plasma da cordone ombelicale: un possibile marcatore di tolerogenicità? 131
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. 131
Can HLA-G predict disease course in rheumatoid arthritis patients? 130
In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment 129
The possible role of HLA-G molecules in human oocyte/embryo secretome 128
Serological and molecular HLA typing in Italian Behcet's patients: significant association to B51-DR5-DQw3 haplotype 128
Ruolo biologico dell'HLA-G solubile nella gravidanza. 126
HLA-G expression and regulation in early embryos 125
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 124
Potential role of soluble HLA-G molecules in multiple sclerosis 123
Totale 20.734
Categoria #
all - tutte 101.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 651
Totale 101.767


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 0 76
2021/20221.697 61 206 101 86 65 60 79 85 69 134 152 599
2022/20231.903 163 128 67 226 318 255 96 208 207 53 114 68
2023/20241.440 91 143 93 47 107 274 75 80 72 101 93 264
2024/20253.908 172 188 300 212 467 335 186 210 584 385 495 374
2025/20268.760 912 437 741 1.091 1.279 618 1.049 430 806 936 345 116
Totale 26.113